Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.
Randomized controlled clinical trials of gabapentin, the 5% lidocaine patch, opioid analgesics, tramadol hydrochloride, and tricyclic antidepressants provide an evidence-based approach to the treatment of neuropathic pain.
Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial.
- R. Portenoy, Elena Doina Ganae-Motan, +6 authors M. Fallon
- MedicineThe journal of pain : official journal of the…
- 1 May 2012
Nabiximols, a novel cannabinoid formulation, may be a useful add-on analgesic for patients with opioid-refractory cancer pain and the efficacy and safety at low and medium doses are demonstrated.
Adult cancer pain.
- R. Swarm, A. Abernethy, +21 authors Rashmi Kumar
- MedicineJournal of the National Comprehensive Cancer…
- 1 September 2010
These NCCN Guidelines provide principles of use, dosing, management of adverse effects, and safe handling procedures of pharmacologic therapies and discuss a multidisciplinary approach for the management of cancer pain.
Controlled‐release oxycodone compared with controlled‐release morphine in the treatment of cancer pain: A randomized, double‐blind, parallel‐group study
While adverse experiences were similar, controlled‐release oxycodone was associated with less itching and no hallucinations, and provides a rational alternative to controlled‐ release morphine for the management of moderate to severe cancer‐related pain.
NCCN clinical practice guidelines in oncology: palliative care.
NCCN Practice Guidelines for Cancer Pain.
The overall approach to pain management encompassed in these guidelines is comprehensive. It is based on objective pain assessments, utilizes both pharmacologic and nonpharmacologic interventions,…
Phantom limb pain and related disorders.
- S. Weinstein
- MedicineNeurologic clinics
- 1 November 1998
Comprehensive evaluation and a multimodality treatment approach comprise the current standard of care of the patient with phantom pain.
Fentanyl pectin nasal spray in breakthrough cancer pain.
- Donald R. Taylor, V. Galan, S. Weinstein, E. Reyes, Ana Rocio Pupo-Araya, R. Rauck
- MedicineThe journal of supportive oncology
- 1 July 2010
Fentanyl pectin nasal spray provided rapid analgesia in BTCP and was well accepted by patients, and satisfaction with the convenience and ease of use of FPNS was reported.
Transdermal fentanyl in children with cancer pain: feasibility, tolerability, and pharmacokinetic correlates.
Treatment of children with TTS-fentanyl is feasible and well tolerated and yields fentanyl pharmacokinetic parameter estimates similar to those for adults, according to a mixed effect modeling approach.
Fentanyl buccal tablet for the treatment of breakthrough pain in opioid‐tolerant patients with chronic cancer pain
This study assessed the long‐term safety and tolerability of fentanyl buccal tablet (FBT) in opioid‐tolerant patients with cancer and breakthrough pain (BTP) who were either naive to FBT or had…